The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Enzyme Replacement Therapy Market Research Report 2025

Global Enzyme Replacement Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1704325

No of Pages : 95

Ask Your Query

Synopsis

Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.

The global Enzyme Replacement Therapy market was valued at US$ 11830 million in 2023 and is anticipated to reach US$ 29910 million by 2030, witnessing a CAGR of 14.0% during the forecast period 2024-2030.

Global Enzyme Replacement Therapy key players include Johnson & Johnson, Allergan, AbbVie, etc. Global top three manufacturers hold a share about 95%.

North America is the largest market, with a share about 70%, followed by Europe, and Asia-Pacific, both have a share over 25 percent.

In terms of product, Oral Agents is the largest segment, with a share nearly 95%. And in terms of application, the largest application is MPS Disease, followed by Gastrointestinal Diseases, Gaucher Disease, Fabry Disease, etc.

This report aims to provide a comprehensive presentation of the global market for Enzyme Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme Replacement Therapy.

Report Scope

The Enzyme Replacement Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enzyme Replacement Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enzyme Replacement Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Sanofi
  • Takeda
  • BioMarin
  • AbbVie
  • Alexion
  • Allergan
  • Horizon Pharma
  • Johnson & Johnson
  • Actelion
  • Recordati Rare Diseases
  • Pfizer
  • Digestive Care
  • Leadiant Biosciences

Segment by Type

  • Injectable Agents
  • Oral Agents

Segment by Application

  • Gaucher Disease
  • Fabry Disease
  • MPS Disease
  • Gastrointestinal Disease
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enzyme Replacement Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enzyme Replacement Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Enzyme Replacement Therapy Market Overview
1.1 Product Overview and Scope of Enzyme Replacement Therapy
1.2 Enzyme Replacement Therapy Segment by Type
1.2.1 Global Enzyme Replacement Therapy Market Value Comparison by Type (2024-2030)
1.2.2 Injectable Agents
1.2.3 Oral Agents
1.3 Enzyme Replacement Therapy Segment by Application
1.3.1 Global Enzyme Replacement Therapy Market Value by Application: (2024-2030)
1.3.2 Gaucher Disease
1.3.3 Fabry Disease
1.3.4 MPS Disease
1.3.5 Gastrointestinal Disease
1.3.6 Others
1.4 Global Enzyme Replacement Therapy Market Size Estimates and Forecasts
1.4.1 Global Enzyme Replacement Therapy Revenue 2019-2030
1.4.2 Global Enzyme Replacement Therapy Sales 2019-2030
1.4.3 Global Enzyme Replacement Therapy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enzyme Replacement Therapy Market Competition by Manufacturers
2.1 Global Enzyme Replacement Therapy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enzyme Replacement Therapy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enzyme Replacement Therapy Average Price by Manufacturers (2019-2024)
2.4 Global Enzyme Replacement Therapy Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enzyme Replacement Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enzyme Replacement Therapy, Product Type & Application
2.7 Enzyme Replacement Therapy Market Competitive Situation and Trends
2.7.1 Enzyme Replacement Therapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enzyme Replacement Therapy Players Market Share by Revenue
2.7.3 Global Enzyme Replacement Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enzyme Replacement Therapy Retrospective Market Scenario by Region
3.1 Global Enzyme Replacement Therapy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enzyme Replacement Therapy Global Enzyme Replacement Therapy Sales by Region: 2019-2030
3.2.1 Global Enzyme Replacement Therapy Sales by Region: 2019-2024
3.2.2 Global Enzyme Replacement Therapy Sales by Region: 2025-2030
3.3 Global Enzyme Replacement Therapy Global Enzyme Replacement Therapy Revenue by Region: 2019-2030
3.3.1 Global Enzyme Replacement Therapy Revenue by Region: 2019-2024
3.3.2 Global Enzyme Replacement Therapy Revenue by Region: 2025-2030
3.4 North America Enzyme Replacement Therapy Market Facts & Figures by Country
3.4.1 North America Enzyme Replacement Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enzyme Replacement Therapy Sales by Country (2019-2030)
3.4.3 North America Enzyme Replacement Therapy Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Enzyme Replacement Therapy Market Facts & Figures by Country
3.5.1 Europe Enzyme Replacement Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enzyme Replacement Therapy Sales by Country (2019-2030)
3.5.3 Europe Enzyme Replacement Therapy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enzyme Replacement Therapy Market Facts & Figures by Country
3.6.1 Asia Pacific Enzyme Replacement Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enzyme Replacement Therapy Sales by Country (2019-2030)
3.6.3 Asia Pacific Enzyme Replacement Therapy Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Enzyme Replacement Therapy Market Facts & Figures by Country
3.7.1 Latin America Enzyme Replacement Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enzyme Replacement Therapy Sales by Country (2019-2030)
3.7.3 Latin America Enzyme Replacement Therapy Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enzyme Replacement Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Enzyme Replacement Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enzyme Replacement Therapy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enzyme Replacement Therapy Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enzyme Replacement Therapy Sales by Type (2019-2030)
4.1.1 Global Enzyme Replacement Therapy Sales by Type (2019-2024)
4.1.2 Global Enzyme Replacement Therapy Sales by Type (2025-2030)
4.1.3 Global Enzyme Replacement Therapy Sales Market Share by Type (2019-2030)
4.2 Global Enzyme Replacement Therapy Revenue by Type (2019-2030)
4.2.1 Global Enzyme Replacement Therapy Revenue by Type (2019-2024)
4.2.2 Global Enzyme Replacement Therapy Revenue by Type (2025-2030)
4.2.3 Global Enzyme Replacement Therapy Revenue Market Share by Type (2019-2030)
4.3 Global Enzyme Replacement Therapy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enzyme Replacement Therapy Sales by Application (2019-2030)
5.1.1 Global Enzyme Replacement Therapy Sales by Application (2019-2024)
5.1.2 Global Enzyme Replacement Therapy Sales by Application (2025-2030)
5.1.3 Global Enzyme Replacement Therapy Sales Market Share by Application (2019-2030)
5.2 Global Enzyme Replacement Therapy Revenue by Application (2019-2030)
5.2.1 Global Enzyme Replacement Therapy Revenue by Application (2019-2024)
5.2.2 Global Enzyme Replacement Therapy Revenue by Application (2025-2030)
5.2.3 Global Enzyme Replacement Therapy Revenue Market Share by Application (2019-2030)
5.3 Global Enzyme Replacement Therapy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Enzyme Replacement Therapy Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Enzyme Replacement Therapy Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 BioMarin
6.3.1 BioMarin Corporation Information
6.3.2 BioMarin Description and Business Overview
6.3.3 BioMarin Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BioMarin Enzyme Replacement Therapy Product Portfolio
6.3.5 BioMarin Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Corporation Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AbbVie Enzyme Replacement Therapy Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Alexion
6.5.1 Alexion Corporation Information
6.5.2 Alexion Description and Business Overview
6.5.3 Alexion Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alexion Enzyme Replacement Therapy Product Portfolio
6.5.5 Alexion Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allergan Enzyme Replacement Therapy Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 Horizon Pharma
6.6.1 Horizon Pharma Corporation Information
6.6.2 Horizon Pharma Description and Business Overview
6.6.3 Horizon Pharma Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Horizon Pharma Enzyme Replacement Therapy Product Portfolio
6.7.5 Horizon Pharma Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Johnson & Johnson Enzyme Replacement Therapy Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Actelion
6.9.1 Actelion Corporation Information
6.9.2 Actelion Description and Business Overview
6.9.3 Actelion Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Actelion Enzyme Replacement Therapy Product Portfolio
6.9.5 Actelion Recent Developments/Updates
6.10 Recordati Rare Diseases
6.10.1 Recordati Rare Diseases Corporation Information
6.10.2 Recordati Rare Diseases Description and Business Overview
6.10.3 Recordati Rare Diseases Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Recordati Rare Diseases Enzyme Replacement Therapy Product Portfolio
6.10.5 Recordati Rare Diseases Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Enzyme Replacement Therapy Description and Business Overview
6.11.3 Pfizer Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Enzyme Replacement Therapy Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Digestive Care
6.12.1 Digestive Care Corporation Information
6.12.2 Digestive Care Enzyme Replacement Therapy Description and Business Overview
6.12.3 Digestive Care Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Digestive Care Enzyme Replacement Therapy Product Portfolio
6.12.5 Digestive Care Recent Developments/Updates
6.13 Leadiant Biosciences
6.13.1 Leadiant Biosciences Corporation Information
6.13.2 Leadiant Biosciences Enzyme Replacement Therapy Description and Business Overview
6.13.3 Leadiant Biosciences Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Leadiant Biosciences Enzyme Replacement Therapy Product Portfolio
6.13.5 Leadiant Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enzyme Replacement Therapy Industry Chain Analysis
7.2 Enzyme Replacement Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enzyme Replacement Therapy Production Mode & Process
7.4 Enzyme Replacement Therapy Sales and Marketing
7.4.1 Enzyme Replacement Therapy Sales Channels
7.4.2 Enzyme Replacement Therapy Distributors
7.5 Enzyme Replacement Therapy Customers
8 Enzyme Replacement Therapy Market Dynamics
8.1 Enzyme Replacement Therapy Industry Trends
8.2 Enzyme Replacement Therapy Market Drivers
8.3 Enzyme Replacement Therapy Market Challenges
8.4 Enzyme Replacement Therapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock